Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

TXMD holding history

TherapeuticsMD, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TXMD overviewAll 13F holders of TXMDFull Q2 2026 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
4
Since Q2 2021
Holdings of TXMD by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−371−100.0%Sold outConverted for a 1-for-50 splitHolders
Q1 202218,537$7.00K<0.1%+136+0.7%AddedHolders
Q4 202118,401$7.00K<0.1%+31+0.2%AddedHolders
Q3 202118,370$14.0K<0.1%−654−3.4%ReducedHolders
Q2 202119,024$23.0K<0.1%+19,024NewHolders